Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)

Summary

Inflammatory cytokines in the cerebrospinal fluid may contribute to the new muscle weakness, fatigue and pain experienced by patients with post-polio syndrome. Intravenousimmunoglobulin (IvIg) reduces this inflammation. The purpose of this study is to investigate the clinical effect of IvIg in post-polio syndrome.

Timeline

Start

2003-08

Primary completion

—

Completion

2004-07

Drugs

Indications